AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01232491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Description: Individually adjusted insulin detemir subcutaneously (under the skin) once daily. Subjects continue their pre-trial metformin treatment.
Study NCT01232491 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary regimen
Description: Subjects receive dietary consultation by a dietician at six occasions during the trial.
Study NCT00898534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bayer DCA2000+ Hemoglobin A1c analyzer
Description: Point-of-care hemoglobin A1c measurement of blood obtained by fingerstick
Study NCT01095419 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage Therapy
Description: After discharge from the intensive care unit to the ward during the postoperative period, patients which were randomized for 3 nights to receive intervention (Massage Therapy)which were consisted of massage of the neck, shoulders, and back. The massage was initiated with light manual compression and progressed to deep compression. The compression was performed with the inner region of the fingers, hand-shaped clamp, and friction (digital compression with the thumb) on trigger points, cervical traction, and mobilization in all planes (front, back, and sides)
Study NCT01095419 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Control
Description: no intervention
Study NCT01854086 — intervention group
Intervention type: OTHER
Intervention: Questionnaires about compliance and persistence with bisphosphonates treatment
Study NCT04594915 — intervention group
Intervention type: DRUG
Intervention: Edoxaban
Description: Edoxaban according to Package Information (Summary of Product Characteristics \[SmPC\]).
Study NCT01293552 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ANT-1207
Description: single dose application
Study NCT03741296 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single stage revision
Description: One-stage exchange hip joint replacement surgery
Study NCT03741296 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Two-stage revision
Description: Two-stage exchange hip joint replacement surgery
Study NCT00553137 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluconazole
Description: 750 mg (5 tablets of 150 mg tablets)taken once
Study NCT00553137 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluconazole
Description: 150 mg fluconazole tablets once daily for 14 days
Study NCT01293552 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Study NCT02785952 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02785952 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT02785952 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab
Description: Given IV
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02785952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03000387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch
Description: Active nicotine patch of 21 mg, 14 mg and 7 mg
Study NCT03000387 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nicotine Patch
Description: Active nicotine patch of 21 mg, 14 mg and 7 mg
Study NCT03000387 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine Patch
Description: Active nicotine patch of 21 mg, 14 mg and 7 mg
Study NCT03000387 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Matching placebo patches of 21 mg, 14 mg and 7 mg
Study NCT02043223 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin A (<3-day postpartum)
Description: Single dose 200,000 IU vitamin A supplementation at \<3-day and placebo supplementation at 6-wk postpartum.
Study NCT02043223 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin A (6 wk postpartum)
Description: Placebo supplementation at \<3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.
Study NCT02043223 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin A (<3-day and 6 wk postpartum)
Description: 200,000 IU vitamin A supplementation, both at \<3-day and 6-wk postpartum
Study NCT02043223 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo supplementation, both at \<3-day and 6-wk postpartum.
Study NCT02074774 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IntellO2
Description: Automated FiO2 regulator that responds to pulse oximetry measures
Study NCT02074774 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual control
Description: Standard practice of manually titrating FiO2 as needed.
Study NCT03375905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cNEP
Description: subjects with OSA will be treated with the cNEP device with the goal of reducing the number of apneas and hypopneas
Study NCT06466928 — intervention group
Intervention type: PROCEDURE
Intervention: Total pancreatectomy
Description: Surgical removal of the entire pancreas
Study NCT00252122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Ketamine. 0.2 mg/kg, intravenously
Study NCT03172611 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Subjects consumed a defined, plant-based diet for 4-weeks. Emphasized were raw fruits and vegetables.
Study NCT03297307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Presurgical Counseling
Description: Children will attend the presurgical counseling visits with their mother
Study NCT03734081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ODC system (type 1 capsule)
Description: ODC (one day capsule) type 1 is ingested by a subject and passes through the gastrointestinal tract. Electrical stimulation is the transferred from the capsule to the surrounding GI tissues. The capsule is excreted from the body through the intestinal tract in a natural manner with bowel movement.
Study NCT03734081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ODC system (type 2 capsule)
Description: ODC (one day capsule) type 2 is ingested by a subject and passes through the gastrointestinal tract. Electrical stimulation is the transferred from the capsule to the surrounding GI tissues. The capsule is excreted from the body through the intestinal tract in a natural manner with bowel movement.
Study NCT02159326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microgynon
Description: single oral tablet dose of Microgynon (0.03 mg EE and 0.15 mg LNG, fasted)
Study NCT02055794 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suturing of the perineal skin
Study NCT02055794 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Closing perineal skin with surgical glue
Study NCT02129647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib
Study NCT02055794 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No suturing of the perineal skin
Study NCT03802318 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rabeprazole
Description: Rabeprazole daily four time (Bid) or daily four times (Qid) Amoxicillin used daily two times (1000 mg bid) or daily four times (500 mg qid) apply in the first line or the second line H pylori eradication therapy
Study NCT03802318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: Rabeprazole daily four time (Bid) or daily four times (Qid) Amoxicillin used daily two times (1000 mg bid) or daily four times (500 mg qid) apply in the first line or the second line H pylori eradication therapy
Study NCT03989986 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iPeer2Peer Mentorship
Description: Mentors and participants can have up to ten Skype calls over the course of 15 weeks.
Study NCT03696966 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Portion-Controlled Meals
Description: Increase dietary structure using portion-controlled meals (PCM)
Study NCT03696966 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Portion-Controlled Meals
Description: Increase dietary structure using portion-controlled meals (PCM)
Study NCT03696966 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low-Calorie Diet
Description: Restrict calorie intake daily
Study NCT03696966 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intermittent Very-Low Calorie Diet
Description: Severely restrict calorie intake intermittently
Study NCT03410966 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: trans cateheter ablation
Description: All AF patients will receive trans catheter ablation by radiofrequency, to destroy arrhythmic atrial cells, and to isolate arrhythmic atrial firing around pulmonary veins' ostia.
Study NCT01368016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine
Description: A single 6 mg dose of an experimental Nicotine Replacement Therapy (NRT), with a 36-hour washout between visits
Study NCT01368016 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine
Description: A single 4 mg dose of a marketed Nicotine Gum, with a 36-hour washout between visits
Study NCT03598478 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TC-MPT
Description: Participants will receive two levels of training within each 90-minute session over a 12-week period: (1) TC training and (2) MPT. The TC training protocol consists of five basic TC movements. After receiving TC training, the participants in this group will take a 5-minute break and then receive MPT. During MPT, the participants will contract their major postural muscles bilaterally as fast as possible against a resistance equivalent to 70% of one repetition maximum.
Study NCT03598478 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TC
Description: Children in the TC group will skip the MPT session and practice TC movements repeatedly for 90 minutes. The exercise progression pattern in the TC-alone group will be the same as that in the TC-MPT group.
Study NCT03598478 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MPT
Description: Those children in the MPT group will perform strengthening exercises repeatedly for 90 minutes, with a short 5-minute break between the three sets of exercises if necessary. The exercise progression pattern in the MPT-alone group will be the same as that in the TC-MPT group.
Study NCT04283552 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamic PET/CT Imaging
Description: -Will take approximately 60 minutes
Study NCT04260906 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vagus nerve stimulator
Description: Vagus nerve stimulation is carried out with a TENS device, which has specially designed surface electrodes in the shape of earphones, the size of which can be selected according to ear size. Electrodes were placed to correspond with the inner and rear surfaces of the tragus and the concha for both ears (Figure 1). The application is carried out, for 30 minutes, using a biphasic, asymmetrical waveform with a pulse duration that is less than 500 microseconds and a frequency of 10 Hertz.
Study NCT04260906 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: The exercise group was assigned a program, which consisted of strengthening, stretching, isometric and posture exercises, targeting the body and upper and lower extremities. That program was home-based and the program was requested to be completed. Patients were asked to attend weekly face to face sessions with a total of 4 of these sessions in the study duration.
Study NCT01921491 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dressing Application
Description: Application of a non-adherent dressing, a moisture retentive dressing, and a multi-layer compression dressing.
Study NCT01921491 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dressing Application
Description: Application of a non-adherent dressing, a moisture retentive dressing, and a multi-layer compression dressing.
Study NCT01921491 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Offloading
Description: Provision of offloading cast walker or similar sponsor-approved device. May convert into instant total contact cast and/or add felt/foam to supplement offloading.
Study NCT01921491 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Offloading
Description: Provision of offloading cast walker or similar sponsor-approved device. May convert into instant total contact cast and/or add felt/foam to supplement offloading.
Study NCT01921491 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Offloading
Description: Provision of offloading cast walker or similar sponsor-approved device. May convert into instant total contact cast and/or add felt/foam to supplement offloading.
Study NCT01370486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: melatonin
Description: melatonin cp 2 mg 1x/d for 1 month
Study NCT01370486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo cp 1x/d for 1 month
Study NCT04732988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSG4112
Description: Once-daily oral administration
Study NCT04732988 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once-daily oral administration
Study NCT00905788 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: prevention of embryo expulsion
Description: The prevention of embryo expulsion will be carried out after embryo transfer
Study NCT00623792 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preoperative lifestyle Intervention
Description: 6 month individual intervention consisting of weekly face-to-face and telephone sessions addressing diet, activity and preparation for surgery, followed by 3 booster telephone calls after surgery
Study NCT03093467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ASCENSO
Description: Internet-based program: an adjunct support and monitoring system for the treatment of depression.
Study NCT03093467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.
Description: Usual psychiatric treatment which may include drugs: antidepressant monotherapy or antidepressants in combination with anxiolytics, neuroleptics or mood stabilizers as needed, according to the psychiatric evaluation. Monthly controls during 5 months in average.
Study NCT03093467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.
Description: Usual psychiatric treatment which may include drugs: antidepressant monotherapy or antidepressants in combination with anxiolytics, neuroleptics or mood stabilizers as needed, according to the psychiatric evaluation. Monthly controls during 5 months in average.
Study NCT03093467 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychotherapy
Description: Usual treatment: brief psychotherapy. One session per week, a total of 9 sessions in average.
Study NCT03093467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Usual treatment: brief psychotherapy. One session per week, a total of 9 sessions in average.
Study NCT00506298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bezafibrate + diflunisal
Description: bezafibrate + diflunisal
Study NCT00506298 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bezafibrate + placebo
Description: bezafibrate + placebo
Study NCT00478478 — intervention group
Intervention type: PROCEDURE
Intervention: Mechanical Thrombectomy
Description: Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.
Study NCT02304952 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency microtenotomy
Description: For the minimally invasive surgery will Arthrocare Topaz MicroDebrider device be used. A small incision will be made and the tip of the device is placed on surface of the tendon to structure and activated for 0.5 second, at 5 mm distance intervals on the tendon creating a grid-like pattern.
Study NCT02304952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric exercise
Description: Eccentric exercise for 3 months. The exercise will be performed once a day with 3 set and 5 reps, women start with 0.5 and men 1.0 kilo with a 10 % increase every week.
Study NCT02304952 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Arthrocare Topaz MicroDebrider
Study NCT01428297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BPR277 ointment (controlled application)
Study NCT01428297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (Vehicle)
Study NCT04555278 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: A figure-of-8 coil connected to a biphasic Magstim Rapid 2 stimulator (The MagstimCo, Whitland, UK) will be used. Coil orientation and position will be guided throughout the experiment by a neuronavigation system (Brainsight, Rogue research, Montreal, QC, Canada). The intensity of rTMS will be set at 95 % of the first dorsal interosseous (FDI) resting motor threshold (RMT).~Active rTMS will consist of 40 trains of 5 seconds each at 10 Hz (25-s intertrain interval) applied over M1 (on FDI cortical representation), for a total of 2000 stimulations lasting 20 minutes.
Study NCT04555278 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: A sham coil will be use (e.g. equipped with a magnetic shield that blocks the magnetic field). The sham stimulation will last the same duration as the active rTMS (30 min).
Study NCT02794571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiragolumab
Description: Several dose levels will be evaluated for tiragolumab administered as a single agent and in combination with atezolizumab and/or other anti-cancer therapies. Tiragolumab will be given via IV infusion on Day 1 of each cycle (21-day or 28-day depending on study cohort and phase) until disease progression or loss of clinical benefit. Those who discontinue treatment with single-agent tiragolumab may receive combination treatment with tiragolumab and atezolizumab and/or other anti-cancer therapies. Combination treatment may continue until disease progression or loss of clinical benefit.
Study NCT04555278 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Control Exercises
Description: The rehabilitation program will consist of a 30-minute session of motor control exercises following the rTMS (Active or Sham) intervention. This approach aims to improve spine health through the optimization of spine loading. The first session will be preceded by an individualized evaluation of the participant's abilities and deficiencies to tailor the training program to each participant.
Study NCT01428297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BPR277 ointment
Study NCT04555278 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Motor Control Exercises
Description: The rehabilitation program will consist of a 30-minute session of motor control exercises following the rTMS (Active or Sham) intervention. This approach aims to improve spine health through the optimization of spine loading. The first session will be preceded by an individualized evaluation of the participant's abilities and deficiencies to tailor the training program to each participant.
Study NCT01368926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO4917523
Description: single oral doses
Study NCT01368926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO4917523
Description: multiple oral doses
Study NCT01368926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: oral doses
Study NCT01358552 — intervention group
Intervention type: OTHER
Intervention: Néevo®/ NéevoDHA®
Description: Néevo®/NéevoDHA® is an orally administered medical food indicated for the dietary management of impaired metabolic processes in women under a doctor's care who face high to intermediate risk pregnancies and are unable to fully metabolize or absorb folic acid. Néevo®/ NéevoDHA® contains L-methylfolate, the biologically active and immediately bioavailable form of folate.
Study NCT01739725 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stent insertion
Description: The patient will receive the helical stent
Study NCT02382549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRAF inhibitor
Description: BRAF inhibitor